Introduction to a New Open Access Journal by MDPI: Journal of Dementia and Alzheimer’s Disease

We are delighted to introduce a new journal dedicated to exploring various forms of dementia, with a specific focus on Alzheimer’s disease [...]


Introduction to a New Open Access Journal by MDPI: Journal of Dementia and Alzheimer's Disease
Magda Tsolaki 1,2 1 Greek Federation of Alzheimer's Disease, 54643 Thessaloniki, Greece; tsolakim1@gmail.com 2 1st Department of Neurology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece We are delighted to introduce a new journal dedicated to exploring various forms of dementia, with a specific focus on Alzheimer's disease [1].This journal will publish original research articles, reviews, and communications that provide fresh perspectives on the full spectrum of dementia disorders, prioritizing studies on Alzheimer's disease and investigations into memory, language, and executive functions.
In the landscape of healthcare, few challenges are as pressing and profound as those posed by dementia and Alzheimer's disease.As the prevalence of these conditions continues to rise globally, the need for innovative research, effective treatments, and compassionate care has never been more urgent.The Journal of Dementia and Alzheimer's Disease (JDAD) stands as a key resource in this field, dedicated to advancing our understanding and management of these complex neurological disorders.
Dementia and Alzheimer's disease not only affect individuals on a deeply personal level but also have far-reaching implications for families, caregivers, and society as a whole.From memory loss and cognitive decline to changes in behavior and loss of independence, the impact of these conditions is profound and diverse.JDAD is committed to focusing on the molecular and cellular aspects of disease onset, risk factors, clinical diagnosis, biomarkers, and treatment options for dementia and Alzheimer's disease, with the ultimate goal of improving outcomes and quality of life for those affected.
Our journal serves as a platform for researchers, clinicians, and caregivers to share their insights and experimental and theoretical results in as much detail as possible.From the cellular and molecular mechanisms of dementia to innovative therapeutic approaches and best practices in care, JDAD covers a wide range of topics relevant to dementia, Alzheimer's disease, and memory.The journal will build substantial international support and strive for a consistently high standard of publication.
At JDAD, we recognize the importance of interdisciplinary collaboration in addressing the complex challenges posed by dementia and Alzheimer's disease.Our editorial team comprises experts from various fields, including neuroscience, geriatrics, neurology, psychiatry, psychology, and public health, who are committed to fostering dialogue and collaboration across disciplines.By bringing together researchers and practitioners from diverse backgrounds, we aim to catalyze innovation and accelerate progress towards effective interventions.
We extend our heartfelt gratitude to the researchers, clinicians, caregivers, and individuals living with dementia and Alzheimer's disease who inspire and inform our work.Your dedication and resilience serve as a constant reminder of the importance of our mission, and we are honored to play a part in advancing the field.
We invite you to join us in our quest to confront dementia and Alzheimer's disease with courage, compassion, and unwavering determination.

Short Biography of Author
Prof. Dr. Magda Tsolaki was born in Thessaloniki, Greece, and studied Medicine (1972)(1973)(1974)(1975)(1976)(1977)(1978) and Theology (1981Theology ( -1985) )  Seven years ago, she was invited to join as a member of the Greek National Observatory for Dementia.She has given more than 875 lectures throughout Greece.She has participated in more than 81 funded research programs and 48 funded clinical trials.In total, she has received 79 awards.Dr. Magda Tsolaki has been the main author of many books (70), and many abstracts for Greek (614) and international (571) conferences.She has participated as an invited speaker at more than 152 meetings/conferences in English and 344 in Greek.Furthermore, she has been a reviewer for conferences and journals ( 430) and has organized 27 national and 5 international conferences on AD.Finally, she was one of three or seven advisory members for 36 completed doctoral theses and 40 postgraduate theses.Pr.Tsolaki is married with four children and ten grandchildren.
Disclaimer/Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s).MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Prof. Dr. Magda Tsolaki was born in Thessaloniki, Greece, and studied Medicine (1972Medicine ( -1978) ) and Theology (1981Theology ( -1985) ) at the Aristotle University of Thessaloniki (AUTh).Afterwards, she initiated her collaboration with AUTh in 1982 as a scientific collaborator and a year later received her specialty as a Neuropsychiatrist and her PhD (1983).She was a Professor of Neurology from 2010, was the Head of the 1st University Department of Neurology (2017Neurology ( -2020) ) and is now an emeritus professor.She founded the Greek Alzheimer Association in 1995 and the Greek Federation of Alzheimer's Disease in 2007, of which she is today the Chair, while also being the scientific director of three Public Dementia Units (founded by her in 2007, 2009 and 2022) for patients with neurodegenerative diseases and their caregivers.She is the first author or co-author of 285 papers in Greek and 119 in English journals outside PubMed and 532 in PubMed (527 as Tsolaki M. and 5 as Costa Tsolaki M.) in English journals with 53,821 (13 June 2024) citations, h-index of 107 and an i10 index of 398 (Google Scholar).Seven years ago, she was invited to join as a member of the Greek National Observatory for Dementia.She has given more than 875 lectures throughout Greece.She has participated in more than 81 funded research programs and 48 funded clinical trials.In total, she has received 79 awards.Prof. Dr. Magda Tsolaki has been the main author of many books (70), and many abstracts for Greek (614) and international (571) conferences.She has participated as an invited speaker at more than 152 meetings/conferences in English and 344 in Greek.Furthermore, she has been a reviewer for conferences and journals (430) and has organized 27 national and 5 international conferences on AD.Finally, she was one of three or seven advisory members for 36 completed doctoral theses and 40 postgraduate theses.Prof. Dr. Tsolaki is married with four children and ten grandchildren.
Disclaimer/Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s).MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
at the Aristotle University of Thessaloniki (AUTh).Afterwards, she initiated her collaboration with AUTh in 1982 as a scientific collaborator and a year later received her specialty as a Neuropsychiatrist and her PhD (1983).She was a Professor of Neurology from 2010, was the Head of the 1st University Department of Neurology (2017-2020) and is now an emeritus professor.She founded the Greek Alzheimer Association in 1995 and the Greek Federation of Alzheimer's Disease in 2007, of which she is today the Chair, while also being the scientific director of three Public Dementia Units (founded by her in 2007, 2009 and 2022) for patients with neurodegenerative diseases and their caregivers.She is the first author or co-author of 285 papers in Greek and 119 in English journals outside PubMed and 532 in PubMed (527 as Tsolaki M and 5 as Costa Tsolaki M.) in English journals with an Impact Factor of 30,908,794, with 53.821 (13 June 2024) citations, an h-index of 107 and an i10 Index of 398.